OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
m (Schedule)
m (Schedule)
Line 221: Line 221:
|4/13/2012  
|4/13/2012  
|Jen Vomaske
|Jen Vomaske
-
|
+
|CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization
|<font color=green> ***Note the location change ***  
|<font color=green> ***Note the location change ***  
|MAC HALL 2201
|MAC HALL 2201

Revision as of 19:01, 10 April 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science.  ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Contents

Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

  • Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
  • Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
follow the instructions for subscribing
  • We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
Fridays 9:15-10:15 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

  • Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date Presenters Topic Links & Comments Location
9/23/2011 Thomas Jacob Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling Dr. Tania Vu’s lab in biomedical engineering
10/7/2011 Brett Sheppard Pancreatic Cancer- Setting the Stage
10/14/2011 Eliot Spindel Targeting cholinergic signaling in lung cancer Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development
10/21/2011 Soren Impey Pancreas
10/28/2011
11/4/2011 Philip Streeter Pancreas: Immunoassays for Detection of Early Pancreatic Cancer
11/11/2011 Joe Gray Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment”
11/18/2011 Fox Lab Pancreas
12/2/2011 Rosie Sears Pancreas:
12/9/2011 Charles Springer Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo?
12/16/2011 Pancreas: Brain Storming
1/6/2012 CANCELLED
1/13/2012

Steve Chui

Shiuh-Wen Luoh

Breast Cancer: I-Spy-2 and tissue collection
1/20/2012

Megan Troxell

Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions
1/27/2012 Joshi Alumkal Thinking Outside the (Androgen) Box in Prostate Cancer
2/3/2012

Rosie Sears

Jim Korkola

Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer
2/10/2012 Steven Jacques Label-free optical imaging of cellular processes
2/17/2012

Lisa Coussens

Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy
2/24/2012 George Thomas Re-thinking Targeted Therapies for Kidney Cancer
3/2/2012 Juha Rantala

Koei Chin

Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays.

Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein

3/9/2012 Daniel Marks Brain Mechanisms in Cancer Cachexia
3/16/2012 Xiangshu Xiao Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy
3/23/2012 Canceled for the 2012 BioMedicine in 4D Conference [1]
3/30/2012 NO MEETING Spring Break
4/6/2012 Allen Ebens, PhD The role of PI3 and PIM kinases in multiple myeloma ***Note the location change *** MAC HALL 2201
4/13/2012 Jen Vomaske CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization ***Note the location change *** MAC HALL 2201
4/20/2012 Zhi Hu

Wassana Yantasee

Part I. Optimization of therapeutic siRNA against HER2 (Hu)

Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee)

***Note the location change *** MAC HALL 2201
4/27/2012 Lucia Carbone Mechanisms of chromosomal rearrangement in evolution and cancer ***Note the location change *** MAC HALL 2201
5/4/2012 Joe Gray

Paul Spellman

Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer

Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA

***Note the location change *** MAC HALL 2201
5/11/2012 Wong Lab (Nick Smith, Emily Bubbers) ***Note the location change *** MAC HALL 2201
5/18/2012 John Muschler

Sunjong Kwon

Breast Cancer ***Note the location change *** MAC HALL 2201
5/25/2012 Liskay Lab Modelling Sporadic Intestinal Cancer ***Note the location change *** MAC HALL 2201
6/1/2012 Brainstorming - Breast Cancer Focus ***Note the location change *** MAC HALL 2201
6/8/2012 Kinrin Yamanaka (Dr. Stephen Lloyd lab) The identification of small molecule inhibitors of DNA polymerase kappa ***Note the location change *** MAC HALL 2201
6/22/2012 Neil Osheroff Vanderbilt ***Note the location change *** MAC HALL 2201
6/29/2012 Jay Nelson Proteomic and genomics in the PNWRCE: a forum for infectious diseases applications to cancer ***Note the location change *** MAC HALL 2201